Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 774

1.

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial.

Washam JB, Hohnloser SH, Lopes RD, Wojdyla DM, Vinereanu D, Alexander JH, Gersh BJ, Hanna M, Horowitz J, Hylek EM, Xavier D, Verheugt FWA, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators.

J Thromb Thrombolysis. 2019 Feb 21. doi: 10.1007/s11239-019-01823-y. [Epub ahead of print]

PMID:
30790160
2.

In middle-aged adults, Astro-CHARM was better than a standard risk factor model for predicting 10-year ASCVD risk.

Nelson AJ, Granger CB.

Ann Intern Med. 2019 Feb 19;170(4):JC23. doi: 10.7326/ACPJ201902190-023. No abstract available.

PMID:
30776812
3.

Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Extremes in Body Weight: Insights from the ARISTOTLE Trial.

Hohnloser SH, Fudim M, Alexander JH, Wojdyla DM, Ezekowitz JA, Hanna M, Atar D, Hijazi Z, Bahit MC, Al-Khatib SM, Lopez-Sendon JL, Wallentin L, Granger CB, Lopes RD.

Circulation. 2019 Feb 18. doi: 10.1161/CIRCULATIONAHA.118.037955. [Epub ahead of print]

PMID:
30773022
4.

Outcomes for Hemodialysis Patients Given Cardiopulmonary Resuscitation for Cardiac Arrest at Outpatient Dialysis Clinics.

Pun PH, Dupre ME, Starks MA, Tyson C, Vellano K, Svetkey LP, Hansen S, Frizzelle BG, McNally B, Jollis JG, Al-Khatib SM, Granger CB; CARES Surveillance Group.

J Am Soc Nephrol. 2019 Feb 7. pii: ASN.2018090911. doi: 10.1681/ASN.2018090911. [Epub ahead of print]

PMID:
30733235
5.

Stroke prevention in atrial fibrillation: Closing the gap.

Pokorney SD, Gersh BJ, Ahmad A, Al-Khatib SM, Blank M, Coylewright M, DiBattiste P, Healey JS, Hedrich O, Hylek EM, Kline-Rogers E, Peterson ED, Mendys P, Mirro MJ, Naccarelli G, Patel P, Ruff CT, Rutman H, Stockbridge N, Temple R, Granger CB.

Am Heart J. 2018 Oct 25;210:29-38. doi: 10.1016/j.ahj.2018.10.004. [Epub ahead of print] No abstract available.

PMID:
30731371
6.

Reply: Delays From First Medical Contact to Revascularization in Patients With ST-Segment Elevation Myocardial Infarction Presenting With Cardiogenic Shock.

Kochar A, Al-Khalidi HR, Doerfler S, Granger CB.

JACC Cardiovasc Interv. 2019 Jan 14;12(1):107. doi: 10.1016/j.jcin.2018.11.024. No abstract available.

PMID:
30621969
7.

Improving Care of STEMI in the United States 2008 to 2012.

Granger CB, Bates ER, Jollis JG, Antman EM, Nichol G, O'Connor RE, Gregory T, Roettig ML, Peng SA, Ellrodt G, Henry TD, French WJ, Jacobs AK.

J Am Heart Assoc. 2019 Jan 8;8(1):e008096. doi: 10.1161/JAHA.118.008096.

8.

Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial.

Alexander KP, Brouwer MA, Mulder H, Vinereanu D, Lopes RD, Proietti M, Al-Khatib SM, Hijazi Z, Halvorsen S, Hylek EM, Verheugt FWA, Alexander JH, Wallentin L, Granger CB; ARISTOTLE Investigators.

Am Heart J. 2019 Feb;208:123-131. doi: 10.1016/j.ahj.2018.09.017. Epub 2018 Nov 22.

PMID:
30579505
9.

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.

Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP.

Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.

PMID:
30571525
10.

Association Between Driving Distance From Nearest Fire Station and  Survival of Out-of-Hospital Cardiac Arrest.

Hansen SM, Hansen CM, Fordyce CB, Dupre ME, Monk L, Tyson C, Torp-Pedersen C, McNally B, Vellano K, Jollis J, Granger CB; CARES Surveillance Group.

J Am Heart Assoc. 2018 Nov 6;7(21):e008771. doi: 10.1161/JAHA.118.008771.

11.

In patients with chest pain, HEART Pathway-guided and usual care did not differ for MACE or health care use.

Limkakeng AT, Granger CB.

Ann Intern Med. 2018 Dec 18;169(12):JC69. doi: 10.7326/ACPJC-2018-169-12-069. No abstract available.

PMID:
30557422
12.

Patterns of use of targeted temperature management for acute myocardial infarction patients following out-of-hospital cardiac arrest: Insights from the National Cardiovascular Data Registry.

Fordyce CB, Chen AY, Wang TY, Lucas J, Goyal A, Wong GC, van Diepen S, Kontos MC, Henry TD, Granger CB, Roe MT.

Am Heart J. 2018 Dec;206:131-133. doi: 10.1016/j.ahj.2018.08.013. Epub 2018 Sep 24.

PMID:
30528916
13.

Risk stratification for stroke in atrial fibrillation: a critique.

Killu AM, Granger CB, Gersh BJ.

Eur Heart J. 2018 Dec 1. doi: 10.1093/eurheartj/ehy731. [Epub ahead of print]

PMID:
30508086
14.

Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial.

Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Siegbahn A, Wallentin L.

Open Heart. 2018 Nov 1;5(2):e000908. doi: 10.1136/openhrt-2018-000908. eCollection 2018.

15.

FDA-Catalyst-Using FDA's Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial.

Cocoros NM, Pokorney SD, Haynes K, Garcia C, Al-Khalidi HR, Al-Khatib SM, Archdeacon P, Goldsack JC, Harkins T, Lin ND, Martin D, McCall D, Nair V, Parlett L, Temple R, McMahill-Walraven C, Granger CB, Platt R.

Clin Trials. 2019 Feb;16(1):90-97. doi: 10.1177/1740774518812776. Epub 2018 Nov 16.

PMID:
30445835
16.

Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: Results of the INFORM-AF study.

Pokorney SD, Bloom D, Granger CB, Thomas KL, Al-Khatib SM, Roettig ML, Anderson J Jr, Heflin MT, Granger BB.

Eur J Cardiovasc Nurs. 2018 Nov 12:1474515118812252. doi: 10.1177/1474515118812252. [Epub ahead of print]

PMID:
30418049
17.

Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study.

Turakhia MP, Desai M, Hedlin H, Rajmane A, Talati N, Ferris T, Desai S, Nag D, Patel M, Kowey P, Rumsfeld JS, Russo AM, Hills MT, Granger CB, Mahaffey KW, Perez MV.

Am Heart J. 2019 Jan;207:66-75. doi: 10.1016/j.ahj.2018.09.002. Epub 2018 Sep 8.

18.

Association of Bystander and First-Responder Efforts and Outcomes According to Sex: Results From the North Carolina HeartRescue Statewide Quality Improvement Initiative.

Malta Hansen C, Kragholm K, Dupre ME, Pearson DA, Tyson C, Monk L, Rea TD, Starks MA, Nelson D, Jollis JG, McNally B, Corbett CM, Granger CB.

J Am Heart Assoc. 2018 Sep 18;7(18):e009873. doi: 10.1161/JAHA.118.009873.

19.

Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.

Luo N, Xu H, Jneid H, Fonarow GC, Lopes RD, Piccini JP, Curtis AB, Russo AM, Lewis WR, Matsouaka RA, Granger CB, Mentz RJ, Al-Khatib SM.

Circ Heart Fail. 2018 Oct;11(10):e005356. doi: 10.1161/CIRCHEARTFAILURE.118.005356.

PMID:
30354398
20.

The changing epidemiology of ventricular arrhythmias and sudden cardiac death: Is it a reality?

Al-Khatib SM, Granger CB.

Heart Rhythm. 2018 Oct 4. pii: S1547-5271(18)31014-2. doi: 10.1016/j.hrthm.2018.09.031. [Epub ahead of print] No abstract available.

PMID:
30291915

Supplemental Content

Loading ...
Support Center